Published in PLoS One on April 26, 2012
Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast. Prion (2014) 0.80
Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease. J Alzheimers Dis (2015) 0.79
Role of membrane biophysics in Alzheimer's-related cell pathways. Front Neurosci (2015) 0.76
Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability. J Physiol (2016) 0.76
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem (1992) 4.66
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem (2004) 4.33
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol (1994) 4.24
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener (2007) 4.15
Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.52
Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology (2004) 2.82
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One (2010) 2.78
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci (2003) 2.63
Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci (2006) 2.47
Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem (2002) 2.45
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A (1993) 2.41
New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev (2008) 2.28
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis (2009) 2.12
Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem (2008) 2.04
Non-conducting functions of voltage-gated ion channels. Nat Rev Neurosci (2006) 2.02
Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain. Eur J Neurosci (1995) 1.94
Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci (2010) 1.78
Kv1.3 channel gene-targeted deletion produces "Super-Smeller Mice" with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron (2004) 1.69
Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol (2006) 1.64
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS One (2008) 1.62
Members of the RCK potassium channel family are differentially expressed in the rat nervous system. EMBO J (1990) 1.55
Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg (2009) 1.55
Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci (2008) 1.54
Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem (2009) 1.53
Tyrosine phosphorylation of the Kv1.3 potassium channel. J Neurosci (1996) 1.47
Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem (2000) 1.47
Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol (2006) 1.41
Modulation of olfactory bulb neuron potassium current by tyrosine phosphorylation. J Neurosci (1998) 1.40
Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol (2008) 1.39
Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys J (2001) 1.37
A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci (2009) 1.36
Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophys J (2008) 1.36
Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology. J Biol Chem (1997) 1.35
Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol (2010) 1.34
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J Biol Chem (2007) 1.30
Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium (2010) 1.29
Protein folding: the endgame. Annu Rev Biochem (1997) 1.25
Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull (2000) 1.25
Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci (2005) 1.24
Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox Res (2009) 1.24
Heterogeneous Expression Patterns of Mammalian Potassium Channel Genes in Developing and Adult Rat Brain. Eur J Neurosci (1992) 1.24
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Size-dependent neurotoxicity of beta-amyloid oligomers. Arch Biochem Biophys (2010) 1.17
Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res (2005) 1.16
Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J (2010) 1.12
Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol (2002) 1.11
Brief review: anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimer's disease. Can J Anaesth (2010) 1.10
N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. J Neurochem (2010) 1.10
Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation. J Neurochem (2006) 1.06
Altered neurogenesis in Alzheimer's disease. J Psychosom Res (2006) 1.03
Neurotrophin B receptor kinase increases Kv subfamily member 1.3 (Kv1.3) ion channel half-life and surface expression. Neuroscience (2006) 1.03
Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease. Anaesthesia (2010) 1.01
Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones. J Neurochem (2001) 1.00
beta-Amyloid increases dendritic Ca2+ influx by inhibiting the A-type K+ current in hippocampal CA1 pyramidal neurons. Biochem Biophys Res Commun (2005) 0.98
A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain. Acta Neuropathol (2009) 0.98
A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci Lett (2009) 0.96
Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J (1996) 0.96
Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochem Biophys Res Commun (2008) 0.95
Decreased proliferation of hippocampal progenitor cells in APPswe/PS1dE9 transgenic mice. Neuroreport (2007) 0.94
Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model. Neuroreport (2009) 0.93
Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience (2002) 0.93
Inhaled anesthetic modulation of amyloid beta(1-40) assembly and growth. Curr Alzheimer Res (2007) 0.92
Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein (1-40) is dependent on solubility status. Brain Res (2002) 0.91
Protofibrils of amyloid beta-protein inhibit specific K+ currents in neocortical cultures. Neurobiol Dis (2003) 0.91
Living with the enemy: a physiological role for the beta-amyloid peptide. Trends Neurosci (2004) 0.88
Recombinant Kv1.3 potassium channels stabilize tonic firing of cultured rat hippocampal neurons. Pflugers Arch (2001) 0.87
Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release. J Alzheimers Dis (2004) 0.85
Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis (2010) 0.83
pH-dependent modulation of Kv1.3 inactivation: role of His399. Am J Physiol Cell Physiol (2004) 0.83
Beta-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia. Neurosci Lett (2001) 0.80
Presence of the voltage-gated potassium channels sensitive to charybdotoxin in inhibitory presynaptic terminals of cultured rat hippocampal neurons. Neurosci Lett (1996) 0.79
Trifluoroacetic acid activates ATP-sensitive K(+) channels in rabbit ventricular myocytes. Biochem Biophys Res Commun (2001) 0.79
Interaction of microglia and amyloid-beta through beta2-integrin is regulated by RhoA. Neuroreport (2008) 0.78
Interfacial effects on the conformation of amyloid-beta peptide. Protein Pept Lett (2009) 0.76
Fibrillar Abeta (1-42) enhances NMDA receptor sensitivity via the integrin signaling pathway. J Alzheimers Dis (2010) 0.76
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol (2005) 13.11
STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature (2005) 8.96
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem (2004) 5.14
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem (2004) 4.33
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem (2005) 4.23
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener (2007) 4.15
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem (2007) 3.42
Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem (2002) 3.37
A transient receptor potential channel expressed in taste receptor cells. Nat Neurosci (2002) 3.35
Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3. J Biol Chem (2008) 2.75
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem (2005) 2.56
Structural brain variation and general intelligence. Neuroimage (2004) 2.49
Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A (2004) 2.32
Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc Natl Acad Sci U S A (2008) 2.22
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis (2009) 2.12
Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem (2006) 2.09
Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem (2008) 2.04
AND/R: Advanced neutron diffractometer/reflectometer for investigation of thin films and multilayers for the life sciences. Rev Sci Instrum (2006) 1.86
The neuroanatomy of general intelligence: sex matters. Neuroimage (2005) 1.85
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature (2012) 1.77
Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol (2006) 1.77
Impaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness. Neuroimage (2003) 1.76
Conformation-dependent anti-amyloid oligomer antibodies. Methods Enzymol (2006) 1.72
Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding. Neurobiol Learn Mem (2003) 1.70
Hemichannel and junctional properties of connexin 50. Biophys J (2002) 1.69
Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol (2006) 1.64
Evidence of the existence of the low-density liquid phase in supercooled, confined water. Proc Natl Acad Sci U S A (2006) 1.62
Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1. J Biol Chem (2005) 1.57
Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem (2008) 1.56
Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.55
Molecular-scale structural and functional characterization of sparsely tethered bilayer lipid membranes. Biointerphases (2007) 1.54
Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol (2009) 1.53
Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A (2005) 1.49
Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab (2006) 1.47
Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry (2007) 1.44
Event-related functional magnetic resonance imaging of a low dose of dexmedetomidine that impairs long-term memory. Anesthesiology (2012) 1.44
NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci (2005) 1.44
Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest (2006) 1.43
The violation of the Stokes-Einstein relation in supercooled water. Proc Natl Acad Sci U S A (2006) 1.41
Molecular basis of pH and Ca2+ regulation of aquaporin water permeability. J Gen Physiol (2004) 1.40
Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates. Proc Natl Acad Sci U S A (2012) 1.39
Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation (2008) 1.38
A new lipid anchor for sparsely tethered bilayer lipid membranes. Langmuir (2009) 1.38
Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity. J Clin Invest (2014) 1.37
A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci (2009) 1.36
Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophys J (2008) 1.36
Polyvalent cations as permeant probes of MIC and TRPM7 pores. Biophys J (2003) 1.36
Returning from oblivion: imaging the neural core of consciousness. J Neurosci (2012) 1.34
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers. Mol Neurodegener (2010) 1.34
Molecular cloning, functional expression, and tissue distribution of a novel human gap junction-forming protein, connexin-31.9. Interaction with zona occludens protein-1. J Biol Chem (2002) 1.33
Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am J Pathol (2009) 1.33
Micro-domains of AQP0 in lens equatorial fibers. Exp Eye Res (2002) 1.32
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J Biol Chem (2007) 1.30
Enzyme activity to augment the characterization of tethered bilayer membranes. J Phys Chem B (2006) 1.29
ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem (2006) 1.28
Structure of functional Staphylococcus aureus alpha-hemolysin channels in tethered bilayer lipid membranes. Biophys J (2009) 1.27
Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain. J Biol Chem (2011) 1.24
CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice. J Neurosci (2011) 1.22
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J Immunol (2012) 1.18
Transformation of plasmid DNA into E. coli using the heat shock method. J Vis Exp (2007) 1.17
Size-dependent neurotoxicity of beta-amyloid oligomers. Arch Biochem Biophys (2010) 1.17
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. J Neurosci (2013) 1.17
Synthesis, DNA affinity, and antiprotozoal activity of linear dications: Terphenyl diamidines and analogues. J Med Chem (2006) 1.17
Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. J Neurosci Res (2006) 1.17
Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res (2005) 1.16
An ion-channel-containing model membrane: structural determination by magnetic contrast neutron reflectometry. Soft Matter (2009) 1.15
The anomalous behavior of the density of water in the range 30 K < T < 373 K. Proc Natl Acad Sci U S A (2007) 1.14
Anomalous x-ray reflectivity characterization of ion distribution at biomimetic membranes. Phys Rev Lett (2003) 1.13
Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy. Proc Natl Acad Sci U S A (2007) 1.12
Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromolecular Med (2007) 1.12
Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection. PLoS One (2012) 1.12
A voxel-based morphometric study of nondemented adults with Down Syndrome. Neuroimage (2003) 1.08
Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue. Acta Trop (2004) 1.08
Single wall carbon nanotubes enter cells by endocytosis and not membrane penetration. J Nanobiotechnology (2011) 1.08
Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry. J Mass Spectrom (2004) 1.05
The species-specific egg receptor for sea urchin sperm adhesion is EBR1,a novel ADAMTS protein. Genes Dev (2003) 1.05
Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis. PLoS Negl Trop Dis (2012) 1.04
Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease. J Neuroinflammation (2005) 1.03
In-plane homogeneity and lipid dynamics in tethered bilayer lipid membranes (tBLMs). Soft Matter (2010) 1.03
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J Neurosci (2013) 1.02
Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metab Dispos (2008) 1.01
Phosphorylation determines the calmodulin-mediated Ca2+ response and water permeability of AQP0. J Biol Chem (2008) 1.00
Structure and properties of tethered bilayer lipid membranes with unsaturated anchor molecules. Langmuir (2013) 0.99
AQP0-LTR of the Cat Fr mouse alters water permeability and calcium regulation of wild type AQP0. Biochim Biophys Acta (2006) 0.98
Allosteric mechanism of water-channel gating by Ca2+-calmodulin. Nat Struct Mol Biol (2013) 0.98